Licensing guidance
This section provides links to the HTA expected standards (Directions) and to guidance for completing the compliance report licence applications.
Please click on the links below to find the guidance you are looking for:
- Expected standards (Directions)
- Guidance for completing compliance report licence applications
- Licensing and consent exemptions from the Human Tissue Act
- Definition of relevant material under the Human Tissue Act
- Policy statement on the relationship between the Advanced Therapy Medicinal Products (ATMP) Regulation and the Quality and Safety Regulations
- Position statement on regulating human embryonic stem cell lines for human application
- Removal of relevant material from deceased children
- Regulatory enforcement policy